BioAtla, Inc. (BCAB) KPIs and segments

BCABOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 4/30

$1.31−0.05 (-3.68%)

Close on Oct 19, 2026Market cap $2.18MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive BioAtla's business

Coming soon

This tab will track the numbers specific to BioAtla's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?